Advanced Viral Research Corp (786623) SEC Filing 8-K Material Event for the period ending Friday, January 23, 2009

Advanced Viral Research Corp

CIK: 786623

View differences made from one to another to evaluate Advanced Viral Research Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Viral Research Corp.


Assess how Advanced Viral Research Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Viral Research Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2009 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 786623
Form Type: 8-K Corporate News
Accession Number: 0000950144-09-000399
Submitted to the SEC: Fri Jan 23 2009 4:09:06 PM EST
Accepted by the SEC: Fri Jan 23 2009
Period: Friday, January 23, 2009
Industry: Pharmaceutical Preparations
  1. Financial Obligation Increase

External Resources:

Bookmark the Permalink: